Similar articles

• [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].

  Higuchi T, Mizunuma H. Higuchi T, et al. Clin Calcium. 2004 Oct;14(10):81-4. Clin Calcium. 2004. PMID: 15577136 Review. Japanese.
• Defining the role of raloxifene for the prevention of breast cancer.

  Kalidas M, Hilsenbeck S, Brown P. Kalidas M, et al. J Natl Cancer Inst. 2004 Dec 1;96(23):1731-3. doi: 10.1093/jnci/djh345. J Natl Cancer Inst. 2004. PMID: 15572750 No abstract available.
• [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].

  Simoncini T, Mannella P, Genazzani AR. Simoncini T, et al. Recenti Prog Med. 2003 Feb;94(2):51-6. Recenti Prog Med. 2003. PMID: 12908369 Review. Italian.
• [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].

  Kozakiewicz K, Wycisk A. Kozakiewicz K, et al. Wiad Lek. 2006;59(5-6):377-82. Wiad Lek. 2006. PMID: 17017486 Review. Polish.
• Raloxifene for the treatment and prevention of breast cancer?

  Pappas SG, Jordan VC. Pappas SG, et al. Expert Rev Anticancer Ther. 2001 Oct;1(3):334-40. doi: 10.1586/14737140.1.3.334. Expert Rev Anticancer Ther. 2001. PMID: 12113100